106 related articles for article (PubMed ID: 31949796)
1. Prognostic value of transducer of ErbB2.1 (TOB1) expression in patients with gastric cancer: tissue microarray analysis.
Yang Y; Shen X; Sun K
Int J Clin Exp Pathol; 2018; 11(8):4060-4066. PubMed ID: 31949796
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of cytoplasmic transducer of ErbB2. 1 expression in gastric cancer.
Zhang SQ; Sun KK; Wu XY; Zhong N; Zhao H; Li DC
Mol Med Rep; 2015 Jul; 12(1):1177-82. PubMed ID: 25760308
[TBL] [Abstract][Full Text] [Related]
3. Decreased TOB1 expression and increased phosphorylation of nuclear TOB1 promotes gastric cancer.
Guan R; Peng L; Wang D; He H; Wang D; Zhang R; Wang H; Hao H; Zhang J; Song H; Sui S; Meng X; Cui X; Bai J; Sun W; Fu S; Yu J
Oncotarget; 2017 Sep; 8(43):75243-75253. PubMed ID: 29088861
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression levels of DAL-1 and TOB1 are associated with clinicopathological features and poor prognosis in gastric cancer.
Guo H; Zhang R; Afrifa J; Wang Y; Yu J
Pathol Res Pract; 2019 Jun; 215(6):152403. PubMed ID: 30962003
[TBL] [Abstract][Full Text] [Related]
5. [Expression of hypoxia-inducible factor 1α in gastric cancer and its clinical signficance].
Wu YL; Hu LN; Zheng CD; Sun RC; Zhang SX; Yan Q; Li YX
Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1418-23. PubMed ID: 27266349
[TBL] [Abstract][Full Text] [Related]
6. TOB1 modulates neutrophil phenotypes to influence gastric cancer progression and immunotherapy efficacy.
Zhang J; Li Y; Chen J; Huang T; Lin J; Pi Y; Hao H; Wang D; Liang X; Fu S; Yu J
Front Immunol; 2024; 15():1369087. PubMed ID: 38617839
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.
Dai W; Ye J; Zhang Z; Yang L; Ren H; Wu H; Chen J; Ma J; Zhai E; Cai S; He Y
Diagn Pathol; 2018 Oct; 13(1):80. PubMed ID: 30326922
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
9. MDM2 binding protein as a predictor of metastasis and a novel prognostic biomarker in patients with gastric cancer.
Wang W; Chen Z; Jin J; Long Z; Liu X; Cai H; Zhou Y; Huang H; Wang Y
Oncol Lett; 2017 Dec; 14(6):6409-6416. PubMed ID: 29422956
[TBL] [Abstract][Full Text] [Related]
10. FTO expression is associated with the occurrence of gastric cancer and prognosis.
Xu D; Shao W; Jiang Y; Wang X; Liu Y; Liu X
Oncol Rep; 2017 Oct; 38(4):2285-2292. PubMed ID: 28849183
[TBL] [Abstract][Full Text] [Related]
11. Enhanced radiosensitivity of NSCLC cells by transducer of erbB2.1 (TOB1) through modulation of the MAPK/ERK pathway.
Sun KK; Zhong N; Yang Y; Zhao L; Jiao Y
Oncol Rep; 2013 Jun; 29(6):2385-91. PubMed ID: 23589165
[TBL] [Abstract][Full Text] [Related]
12. Transducer of ERBB2.1 (TOB1) as a Tumor Suppressor: A Mechanistic Perspective.
Lee HS; Kundu J; Kim RN; Shin YK
Int J Mol Sci; 2015 Dec; 16(12):29815-28. PubMed ID: 26694352
[TBL] [Abstract][Full Text] [Related]
13. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
14. Roles of ZIC family genes in human gastric cancer.
Ma G; Dai W; Sang A; Yang X; Li Q
Int J Mol Med; 2016 Jul; 38(1):259-66. PubMed ID: 27177248
[TBL] [Abstract][Full Text] [Related]
15. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y
Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221
[TBL] [Abstract][Full Text] [Related]
16. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
17. High expression of MRE11 correlates with poor prognosis in gastric carcinoma.
Li J; Su T; Yang L; Zhang C; He Y
Diagn Pathol; 2019 Jun; 14(1):60. PubMed ID: 31221177
[TBL] [Abstract][Full Text] [Related]
18. TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer.
Helms MW; Kemming D; Contag CH; Pospisil H; Bartkowiak K; Wang A; Chang SY; Buerger H; Brandt BH
Cancer Res; 2009 Jun; 69(12):5049-56. PubMed ID: 19491269
[TBL] [Abstract][Full Text] [Related]
19. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis type-1 is a prognostic indicator in human gastric carcinoma.
Liu D; Zhang Y; Li Y; Fan K
Oncotarget; 2017 Oct; 8(47):82910-82919. PubMed ID: 29137312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
